Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Ionis Pharmaceuticals (IONS) Deferred Taxes (2018 - 2020)

Ionis Pharmaceuticals (IONS) has disclosed Deferred Taxes for 3 consecutive years, with $340.1 million as the latest value for Q4 2020.

For Q4 2020, Deferred Taxes rose 10754.14% year-over-year to $340.1 million; the TTM value through Sep 2021 reached $340.1 million, up 22140.18%, while the annual FY2020 figure was $341.7 million, 37411.42% up from the prior year.
Deferred Taxes hit $340.1 million in Q4 2020 for Ionis Pharmaceuticals, up from $1.5 million in the prior quarter.
Across five years, Deferred Taxes topped out at $340.1 million in Q4 2020 and bottomed at -$290.5 million in Q4 2018.
Average Deferred Taxes over 3 years is $5.8 million, with a median of $887000.0 recorded in 2019.
On a YoY basis, Deferred Taxes climbed as much as 10754.14% in 2020 and fell as far as 116.89% in 2020.
Ionis Pharmaceuticals' Deferred Taxes stood at -$290.5 million in 2018, then soared by 98.9% to -$3.2 million in 2019, then soared by 10754.14% to $340.1 million in 2020.
According to Business Quant data, Deferred Taxes over the past three periods came in at $340.1 million, $1.5 million, and $2.5 million for Q4 2020, Q3 2020, and Q2 2020 respectively.